Warby Parker Inc.

NYSE:WRBY

Medical - Instruments & Supplies

Healthcare
$28.22 +3.78%

+$0.92 today

Market cap
$3.07B
Beta
1.97
P/E (TTM)
2305.1
EPS (TTM)
$0.01
52W Low $14.96High $31.00

Volume 5.90M

Average 2.81M

WRBY Interest Expense

Cost of servicing the company's debt during the period.

Warby Parker Inc.NYSE: WRBY

Interest Expense · Q2 FY2026 · quarter ended Jun 2026

Interest expense remains negative

Q2 FY2026 interest expense was $0, compared with $0 a year earlier. Trailing-twelve-month interest expense was $0.

Context

  • Interest expense amounted to 0.0% of revenue in FY2025, unchanged from a year earlier.
  • Interest expense increased in 0 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly interest expense holds near $0 or moves back toward the trailing-twelve-month quarterly average of $0.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterJun 2026
$0— QoQ
Last fiscal yearDec 2025
$0— YoY
LTMJun 2026
$0— YoY
Interest Expense past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter———
1 year———
3-year CAGR———
5-year CAGR——
10-year CAGR——

Interest Expense history

USD · from the income statement

Latest · FY2025
0 USD
Year-over-year change
—

Interest Expense vs competitors

How WRBY compares with its peers on the latest reported figures

  • WRBY's LTM Jun 2026 interest expense of $0 is the 9th highest of the 10 companies compared; the peer median is $82.95M.
  • Interest expense amounts to 0.0% of revenue for WRBY, versus a peer median of 2.4%.
WRBY Competitors Peer median
Interest Expense for WRBY and competitors
Company Period LTM YoY 3-year CAGR% of revenue
BHCBausch Health Companies Inc.LTM Jun 2026$1.61B +8.7%+3.1%14.8%
QDELQuidelOrtho CorporationLTM Mar 2026$186.4M +1.1%+33.6%7.0%
CONConcentra Group Holdings Parent, Inc.LTM Sep 2026$103.76M -0.5%+51.2%4.4%
XRAYDENTSPLY SIRONA Inc.LTM Mar 2026$90M +28.6%+10.6%2.4%
ICUIICU Medical, Inc.LTM Jun 2026$82.95M -21.4%+14.2%3.8%
ITGRInteger Holdings CorporationLTM Jul 2026$38.49M -23.6%+4.3%2.1%
HAEHaemonetics CorporationLTM Jun 2026$30.59M +51.6%+25.2%2.3%
LMATLeMaitre Vascular, Inc.LTM Mar 2026$5.19M +302.6%—2.0%
WRBYWarby Parker Inc.LTM Jun 2026$0 ——0.0%
BEAMBeam Therapeutics Inc.LTM Jun 2026$0 ——0.0%
Peer median (excluding WRBY) $82.95M+4.9%+14.2%2.4%

Competitors are the stored peer set for WRBY. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue540.8M598.11M669.77M771.32M871.91M
Cost of Revenue223.05M257.05M304.54M344.48M401.33M
Gross Profit317.75M341.06M365.22M426.83M470.58M
Gross Margin58.8%57.0%54.5%55.3%54.0%
Research & Development00000
Selling, General & Admin461.41M452.27M421.57M440.05M475.92M
Operating Expenses461.41M452.27M437.22M456.95M475.92M
Depreciation & Amortization21.87M31.86M38.55M45.87M50.28M
EBITDA(122.14M)(78.03M)(24.21M)26.35M53.32M
EBITDA Margin-22.6%-13.0%-3.6%3.4%6.1%
Operating Income(143.66M)(111.2M)(72M)(30.11M)(5.34M)
Operating Margin-26.6%-18.6%-10.7%-3.9%-0.6%
Interest Income01.31M9.23M10.6M8.38M
Interest Expense347K0000
Other Income / Expenses(347K)1.31M9.23M10.6M8.38M
Income Before Tax(144.01M)(109.9M)(62.76M)(19.52M)3.04M
Pre-Tax Margin-26.6%-18.4%-9.4%-2.5%0.3%
Income Tax Expense263K497K433K875K1.4M
Net Income(144.27M)(110.39M)(63.2M)(20.39M)1.64M
Net Margin-26.7%-18.5%-9.4%-2.6%0.2%
EPS (Basic)(1.39)(0.96)(0.54)(0.17)0.01
EPS (Diluted)(1.39)(0.96)(0.54)(0.17)0.01
Weighted Avg Shares113.62M114.94M117.39M120.39M122.67M
Weighted Avg Shares (Diluted)113.62M114.94M117.39M120.39M125.1M

Warby Parker Inc.

NYSE:WRBY

Intrinsic Alpha fair value

Locked

Current Price

$28.22

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.